These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Creutzfeldt-Jakob disease: Australian surveillance update to December 2005. Klug GM; Boyd A; Lewis V; Douglass SL; Argent R; Lee JS; Masters CL; Collins SJ; Commun Dis Intell Q Rep; 2006; 30(1):144-7. PubMed ID: 16637244 [TBL] [Abstract][Full Text] [Related]
9. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007. Shi Q; Gao C; Zhou W; Zhang BY; Chen JM; Tian C; Jiang HY; Han J; Xiang NJ; Wang XF; Gao YJ; Dong XP BMC Public Health; 2008 Oct; 8():360. PubMed ID: 18928564 [TBL] [Abstract][Full Text] [Related]
11. [Study on patients with Creutzfeldt-Jakob disease in Shanghai, 2006-2012]. Huang P; Zhu YY; Hu JY; Jiang CY; Chen B; Zhang H; Chen J Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Sep; 34(9):897-9. PubMed ID: 24331966 [TBL] [Abstract][Full Text] [Related]
12. Mortality trend from sporadic Creutzfeldt-Jakob disease (CJD) in Italy, 1993-2000. Puopolo M; Ladogana A; Almonti S; Daude N; Bevivino S; Petraroli R; Poleggi A; Quanguo L; Pocchiari M J Clin Epidemiol; 2003 May; 56(5):494-9. PubMed ID: 12812825 [TBL] [Abstract][Full Text] [Related]
13. Prion diseases with a focus on Creutzfeldt-Jakob disease, a summary of the incidence of Creutzfeldt-Jakob disease in the Czech Republic over the last 17 years, 2000-2017. Kolářová K; Marešová M; Manďáková Z; Kynčl J Epidemiol Mikrobiol Imunol; 2018; 67(4):155-160. PubMed ID: 30630318 [TBL] [Abstract][Full Text] [Related]
14. Surveillance for Creutzfeldt-Jakob disease--United States. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1996 Aug; 45(31):665-8. PubMed ID: 8769655 [TBL] [Abstract][Full Text] [Related]
16. [Epidemiologic study of Creutzfeldt-Jakob disease from autopsy-confirmed cases]. Iwasaki Y; Mimuro M; Yoshida M; Sobue G; Hashizume Y Rinsho Shinkeigaku; 2009 Aug; 49(8):463-7. PubMed ID: 19827594 [TBL] [Abstract][Full Text] [Related]
17. [Study on the characteristics of patients with Creutzfeldt-Jakob disease under 2008 surveillance data in China]. Tian C; Gao C; Shi Q; Han J; Zhou W; Zhang BY; Gao YJ; Dong XP Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):713-5. PubMed ID: 19957598 [TBL] [Abstract][Full Text] [Related]
18. Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012. Klug GM; Boyd A; Zhao T; Stehmann C; Simpson M; McLean CA; Masters CL; Collins SJ Commun Dis Intell Q Rep; 2013 Jun; 37(2):E115-20. PubMed ID: 24168084 [TBL] [Abstract][Full Text] [Related]
19. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program. Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S Prion; 2015; 9(2):136-43. PubMed ID: 25996401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]